Introduction
============

Members of the Melastomataceae family are widespread in many regions of the world and particularly in tropical and subtropical regions, mainly in South America and South China. Many species of this family are known by their different use in folk medicine as antioxidant \[[@B1-molecules-13-01399]\], antihypertensive \[[@B2-molecules-13-01399]\], antihyperglycemic \[[@B3-molecules-13-01399]\], hemostatic \[[@B4-molecules-13-01399]\] and antihepatitis drugs \[[@B5-molecules-13-01399]\]. Antiinflammatory \[[@B4-molecules-13-01399]\], antimicrobial \[[@B6-molecules-13-01399]\] and cytotoxic effects \[[@B1-molecules-13-01399]\] have also been investigated. Cumulative phytochemical studies of Melastomataceous plants have indicated an abundance of tannins \[[@B7-molecules-13-01399]\], polyphenols \[[@B7-molecules-13-01399]\], flavonoids \[[@B8-molecules-13-01399]\], fatty acids, steroids, and free triterpenoids \[[@B9-molecules-13-01399]\]. The great variety of natural compounds found in this family, as well as their pharmacological properties prompted us to study the chemical constituents and bioactivities of *Sarcopyramis bodinieri* var*. delicate*, an endemic and chemically uninvestigated plant distributed widely in South China.

As a rare species, *Sarcopyramis bodinieri* var*. delicate* was widely used as hepatoprotective drug in Fujian province, China. The water extract of this dried herb could reduce aminotransferase and cure choloplania and hepatoma. Detailed fractionation led to the isolation of two new flavonol glycosides, namely, isorhamnetin-3-*O*-(6′′-*O*-*E*-feruloyl)-*β*-D-glucopyranoside (**1**) and isorhamnetin-3-*O*-(6′′-*O*-*E*-feruloyl)-*β*-D-galactopyranoside (**2**), along with four known compounds. The structures of the new isolates were determined by extensive spectroscopic analysis.([Figure 1](#molecules-13-01399-f001){ref-type="fig"})

![The structures of new compounds **1** and **2**.](molecules-13-01399-g001){#molecules-13-01399-f001}

Results and Discussion
======================

The known compounds **3-6** corresponded to quercetin-3-*O*-(6′′-acetyl)-*β*-D-glucopyranoside (**3**) \[[@B10-molecules-13-01399]\], isorhamnetin-3-*O*-(6′′-acetyl)-*β*-D-glucopyranoside (**4**) \[[@B11-molecules-13-01399]\], quercetin-3-*O*-(6′′-*O*-*E*-*p*-coumaroyl)-*β*-D-glucopyranoside (**5**) \[[@B12-molecules-13-01399]\], and isorhamnetin-3-*O*-(6′′-*O*-*E*-*p*-coumaroyl)-*β*-D-glucopyranoside (**6**) \[[@B13-molecules-13-01399],[@B14-molecules-13-01399]\]. The structures of these known flavonol glycosides were identified on the basis of extensive spectroscopic data analysis and by comparison of their spectral data with those reported in the literature.

![The structures of compounds **3-6**.](molecules-13-01399-g002){#molecules-13-01399-f002}

Compound **1** was isolated as a yellow powder. The molecular formula C~32~H~30~O~15~ was suggested by a mass spectrum with a \[M+Na\]^+^ peak at *m/z* 677, further confirmed by the adduct ions: 693 \[M+K\]^+^, and 1331 \[2M+Na\]^+^, combined with the ^13^C-NMR and DEPT spectra. The IR spectrum of compound **1** revealed the aliphatic and aromatic hydroxyl signals at 3200-3550 cm^-1^. A conjugated carbonyl group (1656 cm^-1^) and an additional *α,β*-unsaturated carbonyl ester group (1724 cm^-1^) were observed in the same region. The absorptions at 3310 and 1057 cm^-1^ indicated the presence of a glycosidic moiety \[[@B15-molecules-13-01399]\].

The ^1^H-NMR spectrum confirmed many of the above features and revealed a set of isorhamnetin signals, a feruloyl group and a glucopyranose moiety. The presence of isorhamnetin was suggested by the following signals: two doublets at *δ*~H~ 6.14 (d, *J* = 1.8 Hz, H-6) and 6.37 (d, *J* = 1.8 Hz, H-8); an ABX spin system due to the aromatic ring at *δ*~H~ 6.90 (d, *J* = 8.6 Hz, H-5′), 7.52 (dd, *J* = 8.6, 1.9 Hz, H-6′) and 7.87 (d, *J* = 1.9 Hz, H-2′); a methoxyl group singlet at *δ*~H~ 3.86 (s, 3′-OMe) with a HMBC correlation with *δ*~C~ 147.1 (C-3′) \[[@B16-molecules-13-01399]\]. In the ^1^H-NMR spectrum another set of ABX-type aromatic proton signals at *δ*~H~ 6.75 (d, *J* = 8.1 Hz, H-5′′′), 6.88 (dd, *J* = 8.1, 1.2 Hz, H-6′′′) and 7.20 (d, *J* = 1.2 Hz, H-2′′′) were observed, together with an additional HMBC crosspeak between *δ*~H~ 3.82 (s, 3′′′-OMe) and *δ*~C~ 147.9 (C-3′′′). Two olefinic protons with a *trans* coupling constant (*J* = 15.8 Hz) at *δ*~H~ 6.22 (d, H-8′′′), 7.34 (d, H-7′′′), which confirmed the presence of an *α,β*-unsaturated carbonyl ester group. The feruloyl structure was then deduced from the HMBC correlation from *δ*~H~ 6.22 (H-8′′′) to *δ*~C~ 126.4 (C-1′′′) and the crosspeaks between H-2′′′/C-7′′′ and H-6′′′/C-7′′′. Detailed analyses of the ^1^H- (*δ* 5.53, d, *J* = 7.8 Hz, H-1′′) and ^13^C-NMR (*δ* 102.8, 77.8, 76.1, 76.0, 71.8, 64.2) suggested glucopyranose as the sugar moiety. A downfield shift of C-6′′ was from *δ*~C~ 61.8 to 64.2, and an upfield shift of C-5′′ was from *δ*~C~ 76.8 to 76.0, which were in accordance with the acylation of C-6′′ of the glucose moiety \[[@B17-molecules-13-01399]\]. Moreover, the downfield shift of H~2~-6′′ to 4.11 (dd, *J* = 6.8, 11.5 Hz) and 4.19 (dd, *J* = 2.1, 11.5 Hz) further confirmed the presence of a C-6′′ feruloyl in compound **1** \[[@B18-molecules-13-01399]\]. Consequently, the structure of compound **1** was established as isorhamnetin-3-*O*-(6′′-*O*-*E*-feruloyl)-*β*-D-glucopyranoside.

Compound **2**, a yellow powder, shared the same molecular formula C~32~H~30~O~15~ with **1**, according to the \[M+Na\]^+^ peak at *m/z* 677 and \[M+K\]^+^ peak at *m/z* 693. Moreover, its NMR data is very similar to those of **1**. Detailed comparison of the ^13^C-NMR and HMQC spectra between the two compounds indicated that the major difference was in the glycoside moiety. The carbon signals at *δ*~C~ 103.4 (C-1′′), 71.2 (C-2′′), 74.6 (C-3′′), 69.5 (C-4′′), 74.3 (C-5′′), and 62.9 (C-6′′) revealed a galactopyranoside moiety \[[@B16-molecules-13-01399]\]. The structure of compound **2** was therefore assigned as isorhamnetin-3-*O*-(6′′-*O*-*E*-feruloyl)-*β*-D-galactopyranoside.

molecules-13-01399-t001_Table 1

###### 

The ^1^H and ^13^C-NMR data of compounds **1** and **2** (DMSO-*d*~6~).

  ---------------------------------------------------------------------------------
  No.        Compound **1**         Compound **2**                          
  ---------- ---------------------- ---------------- ---------------------- -------
  2                                 157.6                                   157.5

  3                                 134.3                                   134.3

  4                                 178.6                                   178.5

  5                                 162.3                                   162.2

  6          6.14 d (1.8)           99.6             6.15 d (1.8)           99.5

  7                                 165.1                                   165.1

  8          6.37 d (1.8)           94.9             6.37 d (1.8)           94.7

  9                                 157.6                                   157.5

  10                                104.9                                   104.9

  1′                                122.3                                   122.2

  2′         7.87 d (1.9)           114.2            7.99 d (1.9)           114.5

  3′                                147.1                                   147.1

  4′                                150.7                                   150.6

  5′         6.90 d (8.6)           116.1            6.89 d (8.6)           116.2

  6′         7.52 dd (8.6, 1.9)     122.9            7.50 dd (8.6, 1.9)     122.9

  1′′        5.53 d (7.8)           102.8            5.52 d (7.8)           103.4

  2′′        3.26 m                 76.1             3.20 m                 71.2

  3′′        3.28 m                 77.8             3.48 m                 74.6

  4′′        3.62 m                 71.8             3.70 m                 69.5

  5′′        3.43 m                 76.0             3.74 m                 74.3

  6′′        4.11 dd (6.8, 11.5)\   64.2             4.12 dd (7.0, 11.8)\   62.9
             4.19 dd (2.1, 11.5)                     4.24 dd (2.1, 11.8)    

  1′′′                              126.4                                   126.4

  2′′′       7.20 d (1.2)           112.1            7.19 d (1.2)           111.7

  3′′′                              147.9                                   147.8

  4′′′                              150.3                                   150.4

  5′′′       6.75 d (8.1)           116.4            6.78 d (8.0)           116.4

  6′′′       6.88 dd (8.1, 1.2)     123.8            6.88 dd (8.0, 1.2)     124.0

  7′′′       7.34 d (15.8)          145.9            7.34 d (15.8)          146.0

  8′′′       6.22 d (15.8)          115.1            6.26 d (15.8)          113.8

  9′′′                              167.5                                   167.2

  3′-OMe     3.86                   56.9             3.87                   56.8

  3′′′-OMe   3.82                   56.6             3.78                   56.2
  ---------------------------------------------------------------------------------

^1^H and ^13^C-NMR spectra were obtained at 600 and 150 MHz, respectively.

The UV spectra of the different flavonol glycosides showed an interesting phenomenon (see [Table 2](#molecules-13-01399-t002){ref-type="table"}) according to our experiments. The substituted fraction on the glycosidic moiety could be characterized by the absorption over 300 nm. For example, the absorption maxima at 315 nm means a *p*-substituted aromatic ring in R~2~, while the absorption at 330-336 nm indicates a tri-substituted aromatic ring in the same position.
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###### 

The UV data for different flavonol glycosides.

![](molecules-13-01399-i001.jpg)

  ---------- ---------------------------------- ----- -----
  Compound   UV (MeOH) *λ*~max~                       
  R~1~       R~2~                                     
  OH         H                                  356   258
  OCH~3~     H                                  354   256
  OH         COCH~3~                            357   256
  OCH~3~     COCH~3~                            355   256
  H          ![](molecules-13-01399-i002.jpg)   315   266
  OH         the same as above                  315   263
  OCH~3~     the same as above                  315   259
  OH         ![](molecules-13-01399-i003.jpg)   333   254
  OCH~3~     ![](molecules-13-01399-i004.jpg)   336   252
  ---------- ---------------------------------- ----- -----

Experimental
============

General
-------

The IR spectra were determined on a Thermo Nicolet Nexus 470 FT-IR spectrometer. Optical rotations were measured with a Perkin-Elmer 243 B polarimeter using a 1 dm microcell. The ^1^H-NMR and ^13^C-NMR spectra were recorded on a Bruker Avance-600 FT NMR spectrometer. ESI-MS were recorded on a PE Q-STAR ESI-TOF-MS/MS spectrometer. Column chromatography was carried with silica gel (200-300 mesh), and HF~254~ silica gel for TLC was obtained from Qingdao Marine Chemistry Co. Ltd., Qingdao, People′s Republic of China. ODS and Sephadex LH-20 (18-110 μm) were obtained from Pharmacia Co.

Extraction and Isolation
------------------------

The specimen of *Sarcopyramis bodinieri* var*. delicate* was collected from Fujian Province, P.R. China, in April 2007. A voucher specimen (RSC07) is deposited at the Department of Pharmacy, School of Medical, Xiamen University. The air-dried plant material (5 kg) was ground and extracted exhaustively by maceration at room temperature with EtOH-H~2~O (70:30, 20 L×3). The concentrated total extract (1.8 kg) was extracted with petroleum ether, CHCl~3~, EtOAc and *n*-BuOH, respectively. Part of the EtOAc portion (SBC, 45 g) was suspended in H~2~O (2 L), and the filter layer was then subjected to D101 macroporous adsorption resin column, eluted with an equivalent H~2~O-EtOH stepwise gradient to obtain 5 fractions. Fraction 3 (SBC-C, 13.76 g) was subjected to a Sephadex LH-20 eluted with MeOH-H~2~O (3:1) to give 6 fractions. Fr. SBC-C3 was subjected to Sephadex LH-20 column and then the repeated silica gel column to give compounds **3** (16.7 mg), **4**(33.4 mg), **5** (18.2 mg), **6** (7.5 mg). Compounds **1** and **2** were repurified from SBC-C3C by semi-preparative reversed-phased HPLC (45% MeOH-H~2~O, YMC-Pack Pro C-18, 20×150 mm) to give 4.6 mg and 5.8 mg, respectively.

*Compound* **1**: ![](molecules-13-01399-i005.jpg) = -48.6 (*c* 0.67, MeOH); UV (MeOH) *λ*~max~ (log *ε*) 251 (4.53), 333 (3.21) nm; IR (neat) *ν*~max~ 3550, 1724, 1656, 1057 cm^-1^; for ^1^H and ^13^C-NMR see [Table 1](#molecules-13-01399-t001){ref-type="table"}; ESI-TOF MS (*m/z*): 677 \[M+Na\]^+^, 693 \[M+K\]^+^, 1331 \[2M+Na\]^+^.

*Compound* **2**: ![](molecules-13-01399-i005.jpg) = -64.2 (*c* 0.24, MeOH); UV (MeOH) *λ*~max~ (log *ε*) 249 (4.47), 334 (3.20) nm; for ^1^H and ^13^C-NMR see [Table 1](#molecules-13-01399-t001){ref-type="table"}; ESI-TOF MS (*m/z*): 677 \[M+Na\]^+^, 693 \[M+K\]^+^.
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